More and more veterinary professionals are embracing a spectrum of care approach–that is, the philosophy that “best medicine” means the care that best fits the pet and family in front of us, even if it’s not the most advanced care available. But, how do we do that without feeling even more vulnerable to lawsuits, board complaints, and angry online reviews?

In this special episode, host Katie Berlin, DVM, is joined by Beth Venit, VMD, MPH, DAVPM, Kate Boatright, VMD, and Sarah L. Babcock, DVM, JD, to address legal and regulatory concerns expressed by veterinary professionals in a discussion about spectrum of care. In most cases, communication, empathy, and concise but thorough recordkeeping are as essential as good medicine, and these three experts offer tips to help us all feel more comfortable with the options we offer. 

Guests: 

• Beth Venit, VMD, MPH, DAVPM, Chief Veterinary Officer, American Association of Veterinary State Boards (AAVSB)
• Sarah J. Babcock, DVM, JD, President, Animal & Veterinary Legal Services, PLLC
• Kate Boatright, VMD, veterinary author and speaker

Resources: 

• AVMA’s list of veterinary state board websites
• Dr. Sarah’s CE courses on medical recordkeeping, ethics, controlled substances, and professional standards of care

Contact:

• [email protected]

Where To Find Us:

• Website: CliniciansBrief.com/Podcasts
• YouTube: Youtube.com/@clinicians_brief
• Facebook: Facebook.com/CliniciansBrief
• LinkedIn: LinkedIn.com/showcase/CliniciansBrief/
• Instagram: @Clinicians.Brief
• X: @CliniciansBrief

The Team:

• Katie Berlin, DVM - Host
• Alexis Ussery - Producer & Multimedia Specialist

In this episode, host Alyssa Watson, DVM, welcomes back Elizabeth Thomovsky, DVM, MS, DACVECC, to discuss her recent Clinician’s Brief article, “Stabilization of Cats With Urethral Obstruction Prior to Referral.” Dr. Thomovsky highlights the importance of recognizing early signs of obstruction, performing prompt physical examinations, and managing associated electrolyte imbalances, including the emergency treatment of hyperkalemia. She also outlines effective analgesia protocols and emphasizes the value of tailored treatment plans and recurrence monitoring, sharing practical tips for general practitioners on the front lines of care.

Resource:

• https://www.cliniciansbrief.com/article/cats-hyperkalemia-stabilization-cystocentesis-catheter

Contact:

• [email protected]

Where To Find Us:

• Website: CliniciansBrief.com/Podcasts
• YouTube: Youtube.com/@clinicians_brief
• Facebook: Facebook.com/CliniciansBrief
• LinkedIn: LinkedIn.com/showcase/CliniciansBrief/
• Instagram: @Clinicians.Brief
• X: @CliniciansBrief

The Team:

• Alyssa Watson, DVM - Host
• Alexis Ussery - Producer & Multimedia Specialist

For the first time in more than a decade, a new Janus kinase (JAK) inhibitor has been approved for veterinary use in the United States. In this episode of Clinician’s Brief Partner Podcast, Dr. Beth invites dermatologist Dr. Andrew Rosenberg to share everything practitioners need to know when it comes to using JAK inhibitors in practice, from the benefits of having options within the drug class to the implications of the boxed warning for the new option.

Sponsored by Elanco

INDICATIONS

Zenrelia is indicated for control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.

IMPORTANT SAFETY INFORMATION

Read the entire package insert before using this drug, including the Boxed Warning. For Full prescribing information call 1 888 545 5973 or visit www.elancolabels.com/us/zenrelia

WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease and inadequate immune response to vaccines. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or dogs with a serious infection. Monitor dogs for infections because Zenrelia may increase susceptibility to opportunistic infections. Neoplastic conditions (benign and malignant) were observed during clinical studies. Consider the risks and benefits of treatment in dogs with a history of recurrence of these conditions. The most common adverse reactions were vomiting, diarrhea and lethargy. Zenrelia has not been evaluated in breeding, pregnant, or lactating dogs and concurrent use with glucocorticoids, cyclosporine, or other systemic immunosuppressive agents has not been tested. For full prescribing information see package insert.

Zenrelia, Elanco, and the diagonal bar logo are trademarks of Elanco or its affiliates. PM-US-24-2291

Contact us:

• [email protected]

Where to find us:

• Cliniciansbrief.com/podcasts
• Facebook.com/clinciansbrief
• Twitter: @cliniciansbrief
• Instagram: @clinicians.brief

The Team:

• Beth Molleson, DVM - Host
• Sarah Pate - Producer & Project Manager, Brief Studio
• Randall Stupka - Podcast Production & Sound Editing

Welcome to the Veterinary Breakroom! Join Alyssa Watson, DVM, and Beth Molleson, DVM, as they discuss the pressing issues impacting the veterinary profession today. In a busy clinic, an unanswered call to a client can cause more than mere frustration. The pet may be under anesthesia or their condition may have worsened, leaving the team in urgent need of client input. Tune in as Dr. Alyssa and Dr. Beth discuss the importance of clear communication with clients about protocols for emergencies when contact cannot be made and share strategies to minimize missed calls.

Contact:

• [email protected]

Where To Find Us:

• Website: CliniciansBrief.com/Podcasts
• YouTube: Youtube.com/@clinicians_brief
• Facebook: Facebook.com/CliniciansBrief
• LinkedIn: LinkedIn.com/showcase/CliniciansBrief/
• Instagram: @Clinicians.Brief
• X: @CliniciansBrief

The Team:

• Alyssa Watson, DVM - Host
• Beth Molleson, DVM - Host
• Alexis Ussery - Producer & Multimedia Specialist

Disclaimer: This podcast recording represents the opinions of Dr. Alyssa Watson and Dr. Beth Molleson. Content is presented for discussion purposes and should not be taken as medical advice. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast.

In this episode, host Alyssa Watson, DVM, talks with Jennifer Granick, DVM, MS, PhD, DACVIM (SAIM), about her recent Clinician’s Brief article, “Top 5 Times to Reconsider Antibiotic Prescriptions.” Dr. Granick discusses scenarios where antibiotics may be misused, emphasizing the importance of understanding the underlying causes of these conditions and the potential harm of unnecessary antibiotic use. She also speaks to the evolving perspectives on the use of metronidazole in veterinary medicine. Finally, Dr. Granick shares strategies for effective client communication, highlighting the significance of relatable analogies and shared experiences.

Resources:

• https://www.cliniciansbrief.com/article/antibiotics-veterinary-treatment-clinical-signs
• https://www.simparicatriodvm.com

Contact:

• [email protected]

Where To Find Us:

• Website: CliniciansBrief.com/Podcasts
• YouTube: Youtube.com/@clinicians_brief
• Facebook: Facebook.com/CliniciansBrief
• LinkedIn: LinkedIn.com/showcase/CliniciansBrief/
• Instagram: @Clinicians.Brief
• X: @CliniciansBrief

The Team:

• Alyssa Watson, DVM - Host
• Alexis Ussery - Producer & Multimedia Specialist

Welcome to the Veterinary Breakroom! Join Beth Molleson, DVM, and Katie Berlin, DVM, as they discuss the pressing issues impacting the veterinary profession today. As 2025 gets underway, we’re all surrounded by messaging telling us it’s time to set goals around health and fitness–and for many of us, that can trigger some uncomfortable feelings and conversations. In this episode, Dr. Beth and Dr. Katie talk about the outsized impact our words can have on ourselves, friends, and colleagues when it comes to food, weight, exercise, and health goals and how to choose language that leaves others feeling seen and supported.

Contact:

• [email protected]

Where To Find Us:

• Website: CliniciansBrief.com/Podcasts
• YouTube: Youtube.com/@clinicians_brief
• Facebook: Facebook.com/CliniciansBrief
• LinkedIn: LinkedIn.com/showcase/CliniciansBrief/
• Instagram: @Clinicians.Brief
• X: @CliniciansBrief

The Team:

• Beth Molleson, DVM - Host
• Katie Berlin, DVM - Host
• Alexis Ussery - Producer & Multimedia Specialist

Disclaimer: This podcast recording represents the opinions of Dr. Beth Molleson and Dr. Katie Berlin. Content is presented for discussion purposes and should not be taken as medical advice. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast.

In this episode, host Alyssa Watson, DVM, welcomes Carrie Schroeder, DVM, DACVAA, to discuss her recent Clinician’s Brief article, “Dexmedetomidine-Induced Bradycardia in a Great Dane.” The conversation centers around the physiological mechanisms underlying bradycardia and dexmedetomidine's biphasic blood pressure effects. Key aspects of the discussion include patient selection, drug combinations, monitoring protocols, and strategies for managing these cases, offering practical guidance on balancing dexmedetomidine’s benefits with its potential risks.

Resource:

• https://www.cliniciansbrief.com/article/heart-rate-veterinary-dexmedetomidine

Contact:

• [email protected]

Where To Find Us:

• Website: CliniciansBrief.com/Podcasts
• YouTube: Youtube.com/@clinicians_brief
• Facebook: Facebook.com/CliniciansBrief
• LinkedIn: LinkedIn.com/showcase/CliniciansBrief/
• Instagram: @Clinicians.Brief
• X: @CliniciansBrief

The Team:

• Alyssa Watson, DVM - Host
• Alexis Ussery - Producer & Multimedia Specialist

Have you ever conducted a food trial only to end up with inconclusive results? Or had it cut short altogether due to compliance issues? In this episode of Clinician’s Brief Partner Podcast, Dr. Beth sits down with Dr. Sarah Ramos, DVM, DACVD, to discuss the best strategies for making food elimination trials a success from start to finish.

Intended for veterinary professionals. Opinions expressed within this content are solely the speaker's and do not reflect the opinions and beliefs of Hill's or its affiliates.  

Sponsored by Hill's Pet Nutrition

Contact us:

• [email protected]

Where to find us:

• Cliniciansbrief.com/podcasts
• Facebook.com/clinciansbrief
• Twitter: @cliniciansbrief
• Instagram: @clinicians.brief

The Team:

• Beth Molleson, DVM - Host
• Taylor Argo - Producer & Project Manager, Brief Studio
• Randall Stupka - Podcast Production & Sound Editing

Welcome to the Veterinary Breakroom! Join Alyssa Watson, DVM, and Katie Berlin, DVM, as they discuss the pressing issues impacting the veterinary profession today. In this episode, they break down the origins and implications of Colorado Proposition 129, which created a new Veterinary Professional Associate (VPA) role in the state. Like many veterinarians and licensed veterinary technicians, Dr. Alyssa and Dr. Katie were curious how such an initiative even made it onto the ballot. They also examine the potential impacts of Proposition 129 on the veterinary field, including its effect on professional roles, education requirements, and the broader future of veterinary care.

Resources:

• https://ballotpedia.org/Colorado_Proposition_129,_Veterinary_Professional_Associate_Initiative_(2024)
• https://www.simparicatriodvm.com

Contact:

• [email protected]

Where To Find Us:

• Website: CliniciansBrief.com/Podcasts
• YouTube: Youtube.com/@clinicians_brief
• Facebook: Facebook.com/CliniciansBrief
• LinkedIn: LinkedIn.com/showcase/CliniciansBrief/
• Instagram: @Clinicians.Brief
• X: @CliniciansBrief

The Team:

• Alyssa Watson, DVM - Host
• Katie Berlin, DVM - Host
• Alexis Ussery - Producer & Multimedia Specialist

Disclaimer: This podcast recording represents the opinions of Dr. Alyssa Watson and Dr. Katie Berlin. Content is presented for discussion purposes and should not be taken as medical advice. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast.

When a new drug class enters the veterinary world, first comes the excitement…then comes the learning. In this episode of Clinician’s Brief Partner Podcast, Jocelyn Mott, DVM, DACVIM, answers your most frequently asked questions when it comes to using a novel drug class in the treatment of feline diabetes mellitus: the sodium-glucose cotransporter-2 inhibitor. Tune in as she explains when, how, and why to consider this option in newly diagnosed feline diabetics.

Sponsored by Elanco

Resource:

• https://my.elanco.com/us/bexacat

Contact us:

• [email protected]

Where to find us:

• Cliniciansbrief.com/podcasts
• Facebook.com/clinciansbrief
• Twitter: @cliniciansbrief
• Instagram: @clinicians.brief

The Team:

• Beth Molleson, DVM - Host
• Taylor Argo - Producer & Project Manager, Brief Studio
• Randall Stupka - Podcast Production & Sound Editing

In this episode, host Alyssa Watson, DVM, is joined by Elizabeth Layne, DVM, DACVD, to discuss her recent Clinician’s Brief article, “Top 5 Topical Therapies to Minimize Systemic Antibiotic Use.” Dr. Layne emphasizes the critical role of topical treatments in veterinary dermatology and their potential to reduce reliance on systemic antibiotics. She explores a variety of therapies–including chlorhexidine, corticosteroids, fluorescent light therapy, epidermal barrier repair agents, and honey–detailing their benefits, risks, and practical applications in managing skin conditions in dogs and cats.

Resources:

• https://www.cliniciansbrief.com/article/treatment-antibiotics-veterinary-skin
• https://www.simparicatriodvm.com

Contact:

• [email protected]

Where To Find Us:

• Website: CliniciansBrief.com/Podcasts
• YouTube: Youtube.com/@clinicians_brief
• Facebook: Facebook.com/CliniciansBrief
• LinkedIn: LinkedIn.com/showcase/CliniciansBrief/
• Instagram: @Clinicians.Brief
• X: @CliniciansBrief

The Team:

• Alyssa Watson, DVM - Host
• Alexis Ussery - Producer & Multimedia Specialist